Pacylex Pharmaceuticals

Focus: Pacylex Pharmaceuticals is a small molecule-focused pharmaceutical company headquartered in Edmonton, Alberta, specializing in neurology and oncology indications. The company is in early-stage development with a focused pipeline of two Phase 1 programs.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Pacylex Pharmaceuticals

AI assessmentNot Hiring

No open roles listed right now. Follow Pacylex Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

PCLX-001 - 20mg

B-cell Non Hodgkin Lymphoma

Phase 1

Clinical Trials (1)

NCT04836195Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma

Phase 1

Help build intelligence for Pacylex Pharmaceuticals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to shape drug development strategy at a focused biotech with two active oncology programs in Phase 1
Small company structure enables direct impact on pipeline decisions and closer collaboration across functions
Based in Edmonton, offering potential cost-of-living advantages and a growing Canadian biotech ecosystem

Watch Out For

No current open positions (0 active job postings) signals potential hiring freeze or very limited growth phase
Early-stage pipeline (both programs in Phase 1) means 5+ years minimum to any potential value inflection or revenue generation
Limited public data on funding, financials, employee count, and recent milestones raises questions about company stability and trajectory

Generated by Claude from Pacylex Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

zelenirstat

Relapsed Adult AML

Phase 1

Clinical Trials (1)

NCT06613217Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia

Phase 1

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Top TAs: Oncology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Oncology

1 pipeline

Marketed

Pipeline